Does TECLISTAMAB Cause Progressive multifocal leukoencephalopathy? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Progressive multifocal leukoencephalopathy have been filed in association with TECLISTAMAB (TECVAYLI). This represents 0.8% of all adverse event reports for TECLISTAMAB.
10
Reports of Progressive multifocal leukoencephalopathy with TECLISTAMAB
0.8%
of all TECLISTAMAB reports
7
Deaths
6
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From TECLISTAMAB?
Of the 10 reports, 7 (70.0%) resulted in death, 6 (60.0%) required hospitalization, and 5 (50.0%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for TECLISTAMAB.
What Other Side Effects Does TECLISTAMAB Cause?
Cytokine release syndrome (257)
Pneumonia (101)
Plasma cell myeloma (100)
Immune effector cell-associated neurotoxicity syndrome (99)
Pyrexia (86)
Covid-19 (82)
Infection (58)
Drug ineffective (52)
Neutropenia (48)
Sepsis (48)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which TECLISTAMAB Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
TECLISTAMAB vs TECLISTAMAB-CQYV
TECLISTAMAB vs TEDIZOLID
TECLISTAMAB vs TEDUGLUTIDE
TECLISTAMAB vs TEDUGLUTIDE\WATER
TECLISTAMAB vs TEGAFUR